Brought to you by 
Metra, Norian form Orquest to commercialize Ultrafiber
13 Jul 1999
Executive Summary
As a joint venture, Metra Biosystems Inc. and Norian Corp. have formed a new company, Orquest Inc., to commercialize a bone-graft substitute using Metra's osteogenic factors and Norian's biomimetic polymer Ultrafiber (mineralized collagen).
Deal Industry
- Biotechnology
- Medical Devices
- Pharmaceuticals
-
Medical Devices
- Biomaterials
Deal Status
- Final
Deal Type
-
Alliance
- Joint Venture
- Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com